US FDA reveals drug center five-year plan
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration's Center for Drug Evaluation and Research has outlined details of its strategies for smarter regulation, scientific innovation, lean management and business innovation aimed at strengthening and enhancing the agency's regulatory operations, addressing certain challenges and delivering on its public health mission over the next five years1.